Literature DB >> 5582955

Chlorpromazine in women with chronic schizophrenia: the effect on cholesterol levels and cholesterol-behavior relationships.

M L Clark, T S Ray, A Paredes, R E Ragland, J P Costiloe, C W Smith, S Wolf.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5582955     DOI: 10.1097/00006842-196711000-00008

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


× No keyword cloud information.
  6 in total

Review 1.  Chlorpromazine dose for people with schizophrenia.

Authors:  Katharine Dudley; Xiaomeng Liu; Saskia De Haan
Journal:  Cochrane Database Syst Rev       Date:  2017-04-13

2.  Letter: Thyrotrophin-releasing hormone, prolactin, and cholesterol.

Authors:  D F Horrobin
Journal:  Br Med J       Date:  1973-12-15

3.  Evidence that chlorpromazine inhibits sterologenesis at post-HMGCoA reductase sites in rat liver, in vitro.

Authors:  F P Bell; E V Hubert
Journal:  Lipids       Date:  1983-09       Impact factor: 1.880

4.  Effect of chlorpromazine on rat arterial lipid synthesis, in vitro.

Authors:  F P Bell; E V Hubert
Journal:  Lipids       Date:  1982-10       Impact factor: 1.880

5.  Inhibition of LCAT in plasma from man and experimental animals by chlorpromazine.

Authors:  F P Bell; E V Hubert
Journal:  Lipids       Date:  1981-11       Impact factor: 1.880

Review 6.  Adverse metabolic effects associated with atypical antipsychotics: literature review and clinical implications.

Authors:  Kristina Melkersson; Marja-Liisa Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.